wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39510346-4BCBB2C6-5CE6-4E8B-B760-C6BD6A6EE33C
Q39510346-4BCBB2C6-5CE6-4E8B-B760-C6BD6A6EE33C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39510346-4BCBB2C6-5CE6-4E8B-B760-C6BD6A6EE33C
A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia.
P2860
Q39510346-4BCBB2C6-5CE6-4E8B-B760-C6BD6A6EE33C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39510346-4BCBB2C6-5CE6-4E8B-B760-C6BD6A6EE33C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
242be03e021c1ed50f584899b4a1a43e68a50502
P2860
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial